(RTTNews) - Boston Scientific Corp. (BSX) announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRM System, the first modular cardiac rhythm management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback